Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination
- PMID: 33798480
- PMCID: PMC8062573
- DOI: 10.1016/j.ajog.2021.03.031
Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination
Figures

References
-
- Centers for Disease Control and Prevention Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. 2021. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considera... Available at:
-
- American College of Obstetricians and Gynecologists Vaccinating pregnant and lactating patients against COVID-19. 2020. https://www.acog.org/en/Clinical/Clinical%20Guidance/Practice%20Advisory... Available at:
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources